Effect of TRAIL on NB4 and K562 cell lines and its relationship with TRAIL receptors expression
- Author:
- No author available
- Journal Title:
- Journal of Leukemia & Lymphoma
- Issue:
- 10
- DOI:
- 10.3760/cma.j.issn.1009-9921.2012.10.003
- Key Word:
- NB4细胞;K562细胞;肿瘤坏死因子相关凋亡诱导配体;死亡受体;欺骗受体;NB4 cells;K562 cells;Tumour necrosis factor related apoptosis-inducing ligand;Death receptor;Decoy receptors
Abstract： Objective To investigate the effect of TRAIL on NB4 and K562 cell lines, and its relationship with TRAIL releptors.Methods Jurkat cells were used as positive control,NB4 and K562 cells were treated with different concentrations of TRAIL. Cell morphologic changes were monitored. The cell proliferation was evaluated by MTT assay. The expression of TRAIL receptor were determined by flow cytometry.Results MTT assay showed that TRAIL inhibited the growth of NB4 and Jurkat cells in vitro in a dose-and time-dependent manner,but the effect of TRAIL on Jurkat cells was stronger than that on NB4 cells.However, the growth of K562 was not inhibited. Flow cytometry analysis revealed that DR4,DR5 and DcR1 were expressed higher in NB4 and K562 cells, but the levels of DR4 and DcR1 were very low in K562 cells.DR5 was expressed in Jurakat cells with low level. No DcR2 was detected on the surface of all the three cell lines.Conclusion NB4 cell line is moderately sensitive to TRAIL,and K562 cell line is resistant to TRAIL.The sensitivity of NB4 cells to TRAIL may be associated with the expression of DcR1, but the sensitivity of K562 cells have nothing to do with the expression of TRAIL receptors.
- [1]郝继辉,郝希山,俞鸣,等.肿瘤坏死因子凋亡诱导配体诱导白血病细胞凋亡中抵抗机制的初步探讨[J].2006,(6).
- [2]Testa U.TRAIL/TRAIL-R in hematologic malignancies.[J].2010,110(1).
- [3]Lalaoui N,Solary E,Schneider P,etc.Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2[J].2006,26(19).
- [4]Zhang B,Zhang Y,Yoshida T.TRAIL induces endocytosis of its death receptors in MDA-MB-231 breast cancer cells.[J].2009,8(10).
- [5]Eva Szegezdi,Carlos R. Reis,Almer M. van der Sloot,etc.Targeting AML through DR4 with a novel variant of rhTRAIL[J].2011,15(10).
- [6]McDonald ER 3rd,Dicker DT,Jin Z,etc.Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.[J].2004,279(34).
- [7]Kim MJ,Kim HB,Kim SH,etc.Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.[J].2009,315(11).
- [8]Ford H,Behbakht K,Thorburn A.TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.[J].2008,11(1).
- [9]Zhang L,Fang B.Mechanisms of resistance to TRAIL-induced apoptosis in cancer.[J].2005,12(3).
- [10]Rossin A,Chomienne C,Raffelsberger W,etc.Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.[J].2001,7(6).
- [11]Avi, Ashkenazi.Targeting death and decoy receptors of the tumour-necrosis factor superfamily.[J].2002,2(6).
- [12]Chai J,Bai HL,Jiang Q,etc.A novel agonistic anti-human death receptor 5 monoclonal antibody with tumoricidal activity induces caspase- and mitochondrial-dependent apoptosis in human leukemia Jurkat cells.[J].2011,26(2).
- [13]Woodward A,Ariail K,Schuh JC,etc.Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo (see comments)[J].1999,5(2).
- [14]Li Y,Tang H,Xu D,etc.Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells[J].2005,280(11).